Providing effective treatment for those with cannabis use disorders is likely to become a matter of growing importance in European drug policy. This is according to the EU drugs agency (EMCDDA) today as it launches a new in-depth study: Treatment of cannabis-related disorders in Europe.
This publication reviews the interventions used in the treatment of cannabis disorders and maps out the geography of cannabis treatment in Europe.
(Lisbon, 15.04.2015) What are the latest drug market trends and what are the factors driving them? What are the most recent developments in drug prevention, treatment and policy? How many new drugs were detected in Europe over the last year and what are the consequences for those using them? These and other questions will be explored in the upcoming European Drug Report 2015 package.
